Literature DB >> 7934807

Acromegaly. Clinical and biochemical features in 500 patients.

S Ezzat1, M J Forster, P Berchtold, D A Redelmeier, V Boerlin, A G Harris.   

Abstract

This prospective study defines the clinical and biochemical features of acromegaly in a large cohort of patients. There was no difference in sex distribution, and for men and women the mean ages at diagnosis (40 +/- 12 and 40 +/- 14 yr, respectively) were similar. Nearly three-quarters of patients were overweight and some 12% severely overweight; the frequency and severity of obesity also was not different between the sexes. Half of patients were hypertensive or were taking anti-hypertensive drugs. Neither GH nor insulin levels were significantly different between normotensive and hypertensive patients. Acral growth and facial coarsening, soft tissue swelling, and excessive perspiration were present in the majority (98%) of patients. Mean serum GH, Sm-C, and PRL levels did not differ between the sexes. Sm-C levels correlated with mean GH concentration (r = 0.31, p < 0.001), both variables inversely related to age. With each decade of life, mean GH and Sm-C levels declined by 7.6 +/- 0.2 ng/mL and 0.5 +/- 0.2 U/mL, respectively. Impaired glucose tolerance was diagnosed in 36% and frank diabetes mellitus in 30% of patients. Hyperprolactinemia was noted in 18% of patients. Galactorrhea was noted in 43 (9%) patients, most of whom were female; the mean GH levels of patients with galactorrhea (60.1 +/- 13 ng/mL) were higher than those of patients without (35.4 +/- 2.6 ng/mL, p = 0.02). Acromegaly appears to afflict men and women equally with a preponderance of presentation in the fourth decade of life.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7934807

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  41 in total

1.  A rare case of gastric cancer in an acromegalic patient.

Authors:  K Asai; S Shimoyama; N Sanno; M Kaminishi; T Oohara
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

2.  Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.

Authors:  Tomris Erbas; Nese Cinar; Selcuk Dagdelen; Arzu Gedik; Hikmet Yorgun; Ugur Canpolat; Giray Kabakci; Mehmet Alikasifoglu
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

3.  Two birds with one stone: octreotide treatment for acromegaly and breast cancer.

Authors:  Young Kwang Chae; Mimi I Hu; Ruth L Katz; Mariana Chavez-MacGregor; Paul Haluska; Funda Meric-Bernstam; Ana M Gonzalez-Angulo; Amal Melhem-Bertrandt
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

Review 4.  Update on prognostic factors in acromegaly: Is a risk score possible?

Authors:  E Fernandez-Rodriguez; F F Casanueva; I Bernabeu
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

5.  Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials.

Authors:  Yong Zhou; Xiao-Ting Wu; Gang Yang; Wen Zhuang; Mao-Ling Wei
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

6.  Peripheral nervous system assessment in acromegaly patients under somatostatin analogue therapy.

Authors:  H Alibas; D Gogas Yavuz; P Kahraman Koytak; M Uygur; T Tanridag; K Uluc
Journal:  J Endocrinol Invest       Date:  2016-08-02       Impact factor: 4.256

7.  A prospective multicenter octreotide dose response study in the treatment of acromegaly.

Authors:  S Ezzat; D A Redelmeier; M Gnehm; A G Harris
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

8.  Mandibular prognathism caused by acromegaly - a surgical orthodontic case.

Authors:  Martin Gosau; Corinna Vogel; Antonios Moralis; Peter Proff; Johannes Kleinheinz; Oliver Driemel
Journal:  Head Face Med       Date:  2009-08-06       Impact factor: 2.151

Review 9.  Nanomedicines in the treatment of acromegaly: focus on pegvisomant.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes Romijn
Journal:  Int J Nanomedicine       Date:  2006

10.  Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes A Romijn
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.